Clin2
NCT06926075Possibly a fitRecruiting

Early trial of KESONOTIDE™ for solid tumors

Prostate CancersBreast CancerLung CancersOvarian CancerGlioblastoma Multiforme (GBM)Pancreas CancerSkin Cancer

Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.

This trial tests a new tablet called KESONOTIDE™ for people with solid tumors that have spread. The goal is to see if it can help when other treatments have stopped working or are not an option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have a solid tumor that has spread (metastatic) or can't be removed with surgery
  • You are still able to do most daily activities on your own (ECOG 0 or 1)
  • Standard treatments have stopped working, you can't take them, or you choose not to take them now
  • You are willing to stop taking anti-inflammatory drugs (including steroids) and statins during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07438782Recruiting· Phase 1
Study of a new drug for advanced solid tumors

This trial tests a new drug, GSK5533524, alone or with other treatments, for people with advanced solid tumors that have stopped responding to standard therapies. It aims to find out if the drug is safe and shows early signs of working.

Philadelphia, Pennsylvania
NCT06736327Recruiting· Phase 1
Testing a new drug, SKB500, for advanced solid tumors

This trial tests a new drug called SKB500 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and may help shrink tumors.

Jilin City
NCT07391644Not yet recruiting· Phase 1
Testing JSKN027 for advanced solid tumors that have progressed

This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.

Beijing, Beijing Municipality
NCT06551142Recruiting· Phase 1
Study of GSK5764227 for advanced solid tumors

This study tests a new drug called GSK5764227 for people with advanced solid tumors. It aims to see if the drug is safe and works against cancer that has stopped responding to other treatments.

Stanford, California
NCT06314373Recruiting· Phase 1/Phase 2
Study of a new drug for advanced solid tumors

This trial tests a new drug called HSK39775 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for people who have few other options.

Shanghai, Shanghai Municipality
NCT07482319Not yet recruiting· Phase 1
Testing a new cell treatment for advanced solid tumors

This trial tests an injection of your own immune cells (tumor-infiltrating lymphocytes) to see if they can fight advanced solid tumors like stomach or lung cancer. Doctors will remove one of your tumors, grow the immune cells from it, and then give them back to you.

Beijing

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.